Malabsorption News

Hydrogen breath tests could help diagnose treatable conditions in patients with suspected functional dyspepsia, according to research published in Digestion.

PHILADELPHIA — As much as one-third of food labeled as gluten-free in restaurants are contaminated with gluten, according to research presented at the American College of Gastroenterology Annual Meeting.

PHILADELPHIA — Patients with celiac disease who rely on symptoms to know when they have been exposed to gluten have trouble determining if they have truly ingested gluten, according to research presented at the American College of Gastroenterology Annual Meeting.

September 13 is recognized as National Celiac Disease Awareness Day, a day set aside to educate the public and raise awareness about the disease.

Dietary gluten intake does not appear to be linked to a risk for microscopic colitis in women, according to research published in The American Journal of Gastroenterology.

About a decade ago, celiac disease experts worldwide were struck by the number of individuals being seen and claiming gluten sensitivity. This came as a surprise to celiac disease experts and although we could not find an explanation for it, there developed an academic interest as more of us experienced this influx of patients.

When it comes to gluten-specific conditions, celiac disease is by far the most well-known. An estimated 2.5 million Americans are affected by the disease, and its main treatment, the gluten-free diet, has become part of the mainstream culture as a fad diet or near cure-all for diet-related problems. The science on celiac spans back several decades and has provided clinicians with a bevy of diagnostic tools at their disposal, though many individuals with celiac disease may still be undiagnosed.

WASHINGTON — Most individuals on a gluten-free diet do not avoid gluten because of specific gluten-related symptoms, according to data presented at Digestive Disease Week.

WASHINGTON — Women in the general population are more likely to have undiagnosed celiac disease, and the difference is even more pronounced in younger girls, according to data presented at Digestive Disease Week.

WASHINGTON — AMG 715, an investigational anti-interleukin 15 inhibitor, showed safety and efficacy for stopping the progression of refractory celiac disease type II, according to phase 2 randomized controlled trial data presented at DDW 2018.